E213 - Metabolic dysfunction–associated fatty liver disease an update
From Australian Prescriber Podcast by Australian Prescriber
April 27, 2026 · 16 min · Episode 213
About this episode
Laura Beaton interviews Richard O'Halloran about metabolic dysfunction–associated fatty liver disease, discussing risk factors, diagnostic tests, and management strategies.
Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities to consider, and diagnostic tests for MAFLD. The conversation also covers management of MAFLD through risk stratification, addressing health risk behaviours, and surveillance. Read the full article in Australian Prescriber .
People in this episode
Host: Laura Beaton
Guest: Richard O'Halloran
Topics covered
- metabolic dysfunction
- fatty liver disease
- hepatology
- risk factors
- diagnostic tests
- management
- health risk behaviours
Keywords
- MAFLD
- metabolic dysfunction
- fatty liver
- hepatology
- risk stratification
- health behaviours
- surveillance
Mentioned in this episode
Books & works: Australian Prescriber
More episodes of Australian Prescriber Podcast
- E212 - Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals · April 13, 2026 · 24 min
- E211 - Preventing infections in immunosuppressed patients · March 30, 2026 · 24 min
- E210 - Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis – is it effective? · March 16, 2026 · 19 min
- E209 - Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline · March 2, 2026 · 24 min
- E208 - Pharmacological management of attention deficit hyperactivity disorder in adults · February 16, 2026 · 21 min
- E207 - Injectable drugs for weight management · February 2, 2026 · 23 min
Explore listener stats, chart rankings, contacts and more on the Australian Prescriber Podcast podcast page.